New prostate cancer drug study halted early
NCT ID NCT04631601
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study aimed to test the safety and effectiveness of new drugs for men with a type of advanced prostate cancer that no longer responds to hormone therapy. It enrolled 65 adults with confirmed cancer. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akademiska sjukhuset
Uppsala, 75185, Sweden
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Karolinska Universitetssjukhuset Solna
Stockholm, 171 76, Sweden
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Rigshospitalet
København Ø, 2100, Denmark
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
Skanes universitetssjukhus
Lund, 221 85, Sweden
-
St Vincents Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California San Francisco Mission Bay Campus
San Francisco, California, 94158, United States
-
University of California at Irvine Medical Center
Orange, California, 92868, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.